BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6331461)

  • 1. Calcium pyrophosphate crystal deposition. An in vitro study using a gelatin matrix model.
    Mandel NS; Mandel GS; Carroll DJ; Halverson PB
    Arthritis Rheum; 1984 Jul; 27(7):789-96. PubMed ID: 6331461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for human calcium pyrophosphate crystal deposition disease: crystallization kinetics in a gelatin matrix.
    Mandel NS; Mandel GS
    Scan Electron Microsc; 1984; (Pt 4):1779-92. PubMed ID: 6098005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model.
    Mandel GS; Halverson PB; Rathburn M; Mandel NS
    Scanning Microsc; 1990 Mar; 4(1):175-9; discussion 179-80. PubMed ID: 2164257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium pyrophosphate crystal deposition: the effect of monosodium urate and apatite crystals in a kinetic study using a gelatin matrix model.
    Mandel GS; Halverson PB; Mandel NS
    Scanning Microsc; 1988 Jun; 2(2):1189-98. PubMed ID: 2840735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium pyrophosphate crystal deposition: the effect of soluble iron in a kinetic study using a gelatin matrix model.
    Mandel GS; Halverson PB; Mandel NS
    Scanning Microsc; 1988 Jun; 2(2):1177-88. PubMed ID: 2840734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium pyrophosphate crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP; Adams ME; Nyburg SC; Omar SA
    J Rheumatol; 1980; 7(5):609-16. PubMed ID: 6255159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium pyrophosphate crystal deposition in model systems.
    Mandel N; Mandel G
    Rheum Dis Clin North Am; 1988 Aug; 14(2):321-40. PubMed ID: 2845492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels.
    Hunter GK; Grynpas MD; Cheng PT; Pritzker KP
    Calcif Tissue Int; 1987 Sep; 41(3):164-70. PubMed ID: 2822212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1981; 8(5):772-82. PubMed ID: 6273554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of calcium pyrophosphate crystals in vitro: implications for calcium pyrophosphate crystal deposition disease (pseudogout).
    Hearn PR; Russell RG
    Ann Rheum Dis; 1980 Jun; 39(3):222-7. PubMed ID: 6251756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histochemical localization of calcium with potassium pyroantimonate in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K
    Clin Orthop Relat Res; 1991 Mar; (264):286-94. PubMed ID: 1705190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium pyrophosphate dihydrate crystal formation in model hydrogels.
    Pritzker KP; Cheng PT; Adams ME; Nyburg SC
    J Rheumatol; 1978; 5(4):469-73. PubMed ID: 216804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and membranolytic effects of triclinic calcium pyrophosphate dihydrate crystals.
    Burt HM; Jackson JK
    J Rheumatol; 1987 Oct; 14(5):968-73. PubMed ID: 2828618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
    So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
    J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
    Pritzker KP; Cheng PT; Renlund RC
    J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrous [Fe++] but not ferric [Fe] ions inhibit de novo formation of calcium pyrophosphate dihydrate crystals: possible relationships to chondrocalcinosis and hemochromatosis.
    Cheng PT; Pritzker KP
    J Rheumatol; 1988 Feb; 15(2):321-4. PubMed ID: 2834554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of monoclinic calcium pyrophosphate dihydrate (m-CPPD) involved in inflammatory reactions and osteoarthritis.
    Gras P; Rey C; André G; Charvillat C; Sarda S; Combes C
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Feb; 72(Pt 1):96-101. PubMed ID: 26830800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic localization of lipid in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K; Masuda I; Yokoyama M; Honda I
    Arthritis Rheum; 1988 Aug; 31(8):1057-62. PubMed ID: 2457374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium pyrophosphate dihydrate crystal deposition patterns in the triangular fibrocartilage complex.
    Berger RA; Buckwalter JA
    Orthopedics; 1990 Jan; 13(1):75-80. PubMed ID: 2153953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout.
    Swan A; Heywood B; Chapman B; Seward H; Dieppe P
    Ann Rheum Dis; 1995 Oct; 54(10):825-30. PubMed ID: 7492222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.